McKay, Campbell J. L. https://orcid.org/0009-0006-3497-3144
Mayoh, Chelsea https://orcid.org/0000-0002-6398-3046
Power, Phoebe
Jessop, Sophie
Sriharan, Shampavi
Staunton, Jordan
Trinder, Sarah
Zhukova, Nataliya
Mignone, Cristina
Govender, Dinisha
Alvaro, Frank
Downie, Peter https://orcid.org/0000-0002-6616-5102
Hansford, Jordan R. https://orcid.org/0000-0001-7733-383X
Hassall, Tim
Valvi, Santosh
Mateos, Marion K. https://orcid.org/0000-0002-2763-5853
Barahona, Paulette https://orcid.org/0000-0002-3184-8499
Gifford, Andrew J. https://orcid.org/0000-0002-4092-2347
Tax, Gabor https://orcid.org/0000-0003-4530-0798
Tsoli, Maria https://orcid.org/0000-0003-1155-0510
Dolman, Emmy M.
Wong, Marie https://orcid.org/0000-0003-0066-6606
Cowley, Mark https://orcid.org/0000-0002-9519-5714
Marshall, Glenn M. https://orcid.org/0000-0002-2503-0762
Trahair, Toby N. https://orcid.org/0000-0002-3295-228X
Ekert, Paul G. https://orcid.org/0000-0002-2976-8617
Haber, Michelle https://orcid.org/0000-0003-2036-8817
Tyrell, Vanessa https://orcid.org/0000-0002-5162-517X
Lau, Loretta M. S. https://orcid.org/0000-0002-3172-0970
Manoharan, Neevika
Ziegler, David S. https://orcid.org/0000-0001-7451-7916
Khuong-Quang, Dong-Anh https://orcid.org/0000-0001-6305-7790
Article History
Received: 30 May 2025
Accepted: 22 April 2026
First Online: 19 May 2026
Competing interests
: D.S.Z. reports consulting / advisory board fees from Medison Pharma, Amgen, Novartis and Roche and research support from Accendatech. The remaining authors declare no competing interests.